|
GNPDA2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.0524999999978E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.048130E-02 |
| Normal-vs-Stage2 |
3.826800E-01 |
| Normal-vs-Stage3 |
2.08329999995538E-06 |
| Normal-vs-Stage4 |
7.76470000518614E-08 |
| Stage1-vs-Stage2 |
7.634800E-01 |
| Stage1-vs-Stage3 |
1.876570E-03 |
| Stage1-vs-Stage4 |
1.040130E-04 |
| Stage2-vs-Stage3 |
9.461700E-02 |
| Stage2-vs-Stage4 |
5.264000E-02 |
| Stage3-vs-Stage4 |
6.417200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.237060E-04 |
| Normal-vs-AfricanAmerican |
2.399200E-04 |
| Normal-vs-Asian |
2.828200E-01 |
| Caucasian-vs-AfricanAmerican |
3.197600E-01 |
| Caucasian-vs-Asian |
8.066200E-01 |
| AfricanAmerican-vs-Asian |
5.003200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.188660E-04 |
| Normal-vs-Female |
6.361400E-04 |
| Male-vs-Female |
7.864400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.203400E-03 |
| Normal-vs-Age(41-60Yrs) |
1.358850E-03 |
| Normal-vs-Age(61-80Yrs) |
2.431600E-04 |
| Normal-vs-Age(81-100Yrs) |
1.751600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.974000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.613000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.872400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.476400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.610400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.252000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.295800E-01 |
| Normal-vs-Grade 2 |
1.289570E-01 |
| Normal-vs-Grade 3 |
4.47329999708757E-08 |
| Normal-vs-Grade 4 |
3.70489972034704E-10 |
| Grade 1-vs-Grade 2 |
2.005800E-01 |
| Grade 1-vs-Grade 3 |
2.737300E-03 |
| Grade 1-vs-Grade 4 |
1.018530E-04 |
| Grade 2-vs-Grade 3 |
1.788460E-04 |
| Grade 2-vs-Grade 4 |
1.37310000036805E-07 |
| Grade 3-vs-Grade 4 |
6.262100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.260800E-01 |
| Normal-vs-ccB subtype |
2.46899999999384E-05 |
| ccA subtype-vs-ccB subtype |
1.139060E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.157800E-03 |
| Normal-vs-N1 |
2.363100E-03 |
| N0-vs-N1 |
2.896000E-01 |
|
|
